Elite in Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2)

Patrick Edery

Service De Génétique Et Centre De Référence Maladies Rares Des Anomalies Du Développement CLAD Sud Est, 
Lyon, FR 
Elite in Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2)
Service De Génétique Et Centre De Référence Maladies Rares Des Anomalies Du Développement CLAD Sud Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Patrick Edery practices in Lyon, France. Edery and is rated as an Elite expert by MediFind in the treatment of Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2). His top areas of expertise are Microcephalic Osteodysplastic Primordial Dwarfism Type 1 (MOPD1), Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2), Microcephaly, and Achalasia Microcephaly Syndrome.

His clinical research consists of co-authoring 128 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2).

Gender
Male

Locations

Service De Génétique Et Centre De Référence Maladies Rares Des Anomalies Du Développement CLAD Sud Est, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Etude Pilote Des différentes stratégies de séquençage Haut débit du génome Pour le Diagnostic génétique Des Patients Atteints de déficience Intellectuelle
Etude Pilote Des différentes stratégies de séquençage Haut débit du génome Pour le Diagnostic génétique Des Patients Atteints de déficience Intellectuelle
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Genetic
Study Phase: Not Applicable

128 Total Publications

Germline mutations in a G protein identify signaling cross-talk in T cells.
Germline mutations in a G protein identify signaling cross-talk in T cells.
Journal: Science (New York, N.Y.)
Published: September 19, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile